TARDBP and amyotrophic lateral sclerosis: This finding is particularly clinically relevant as 90% of ALS cases are sporadic.29 Establishing the existence of such species next allowed us to prove that an anti-TDP-43 mAb, such as ACI-5891.9, would neutralize this pathological activity when provided in sufficient quantities.